| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |